Clinicopathologic correlations of renal microthrombosis and inflammatory markers in proliferative lupus nephritis-Reference-Cited by-同舟云学术

Clinicopathologic correlations of renal microthrombosis and inflammatory markers in proliferative lupus nephritis

Published:2012 Issue:3 Volume:14 Page:R126
ISSN:1478-6354
Container-title:Arthritis Research & Therapy
language:en
Short-container-title:Arthritis Res Ther

Author:

Gonzalo Elena,Toldos Oscar,Martínez-Vidal María P,Ordoñez María C,Santiago Begoña,Fernández-Nebro Antonio,Loza Estíbaliz,García Isabel,León Myriam,Pablos José L,Galindo María

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy,Rheumatology

Reference18 articles.

1. Monitoring urinary levels of monocyte chemotactic and activating factor reflects disease activity of lupus nephritis

2. A new morphologic index for the evaluation of renal biopsies in lupus nephritis

3. Renal Vascular Lesions in Lupus Nephritis

4. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: Prevalence, clinical associations, and long-term outcome

5. Immunohistochemical detection of intravascular platelet microthrombi in patients with lupus nephritis and anti-phospholipid antibodies

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endothelial Dysfunction Biomarkers and CKD Incidence in the REGARDS Cohort;Kidney International Reports;2024-07

2. Complement C4d as a biomarker for systemic lupus erythematosus and lupus nephritis;Lupus;2024-01-16

3. Renal C4d is a potential biomarker of disease activity and severity in pediatric lupus nephritis patients;Frontiers in Pediatrics;2023-06-01

4. Increased risk of acute and chronic microvascular renal lesions associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: A systematic review and meta-analysis;Autoimmunity Reviews;2022-10

5. The association of urinary plasmin level with renal involvement and disease flare among systemic lupus erythematosus patients;Archives of Rheumatology;2022-05-06